在当前的时代,抗癌药物的发展
Bradley J Monk1, Manish R Patel2, Sarper Toker3
1Late Phase Clinical Research, Florida Cancer Specialists and Research Institute, West Palm Beach, FL 33401, USA.
Cancer treatment and research communications
|September 30, 2025
概括
开发新的抗癌药物是复杂的. 本综述综合了最佳实践和美国食品和药物管理局 (FDA) 关于有效抗癌药物开发和临床试验的指导.
科学领域:
- 在瘤学瘤学.
- 制药科学 制药科学
- 监管事务 监管事务
背景情况:
- 抗癌药物开发是一个技术上苛刻的过程,存在重大监管障碍.
- 赞助商经常因缺乏对监管任务和流程的认识而面临延误.
- 关键阶段包括分子发现,临床前测试和人类临床试验,化学,制造和控制 (CMC) 对质量至关重要.
研究的目的:
- 总结和综合最佳实践,以推动抗癌药物进入临床环境.
- 将美国食品和药物管理局 (FDA) 的最新指南纳入药物开发过程.
- 解决早期临床试验的挑战,包括剂量优化和可解释性.
主要方法:
- 对当前文献的审查和瘤药物开发最佳实践的综合.
- 分析一期临床试验设计和执行的最新进展.
- 整合美国FDA与药物批准和临床试验有关的指导方针.
主要成果:
- 最近的进展提高了第一阶段试验的效率并降低了成本,尽管复杂性增加了.
- 剂量扩展队列提供了概念证明,但需要仔细解释,特别是没有控制臂.
- 多样性计划对于了解不同人群的有效性和安全性至关重要.
结论:
- 实施最佳实践和遵守监管指导可以简化新型抗癌疗法的开发.
- 解决试验设计中的挑战,如剂量优化和多样性,对于稳健的临床评估至关重要.
- 网络和集中流程可以显著提高临床试验的速度,效率和成本效益.
关键词:
在当前时代的抗癌药物开发.相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


